Global Opioids Drugs MarketPosted by pallavi on January 6th, 2021 Global opioids drugs market was valued US$ 22.85 Bn in 2019 and is expected to reach US$ 32.6 Bn by 2026, at a CAGR of 4.54 % during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Opioids are narcotic drugs act on the nervous system and used to reduce pain, but can also have serious risks and side effects. Side Effects of Opioids: Opioids are mainly used in cancer pain management and end-stage diseases in which painkilling care is required. The rising prevalence of cancer, high demand for pain therapeutics in the treatment of chronic pain, regulatory approvals & launches of innovative drug formulations, and increasing approval rate of abuse-deterrent formulations of opioid drugs are major driving factors of the global opioids drugs market. Extensive misuse of opioids, the growing incidence of death related to opioid overdose, and rising number of lawsuits against opioid manufacturers are hindering the growth of the market. Oxycodone holds the largest market share in terms of product, owing to the used to help relieve moderate to severe pain. It works in the brain to change how your body feels and responds to pain. Oxycodone may cause side effects such as dry mouth, stomach pain, drowsiness, flushing, headache, and mood changes. Anesthesia is the majorly used application in the opioids drugs market. A major benefit of opioid anesthesia is the cardiovascular stability obtained during orientation and throughout the operation, even in patients with severely impaired cardiac function. According to health experts, the risk of complications during anesthesia are increased due to the rising rate of smoking, high blood pressure, diabetes, obstructive sleep arena and lung related to heart, and drug allergies or the past reactions related to anesthesia. North America is the leading opioids drugs market and accounting for nearly 65% revenue share, followed by Europe. Due to growing painkilling care facilities, reformed regulations for prescription of opioids, and extensive focus of generic manufacturers towards Abuse-Deterrent Formulation (ADF) are expected to drive the growth of the opioids market in North America, followed by Europe. The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market. For More Information Visit : https://www.maximizemarketresearch.com/market-report/global-opioids-drugs-market/23754/
Global Opioids Drugs Market, by Products: • Buprenorphine • Anesthesia • North America • Acura Pharmaceuticals Inc. This Report Is Submitted By : Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address : Pune, Maharashtra 411051, India. Contact: +919607195908 Like it? Share it! More by this author |